检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Supplementary Figure S1 from Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort

Akihito Kawazoe,Noboru Yamamoto,Naotoshi Sugimoto,Hisato Kawakami,Takashi Oshima,Kensei Yamaguchi,Kaori Hino,Motohiro Hirao,Yukinori Kurokawa,Takeshi Kawakami,Masahiro Tsuda,Hiroki Hara, Shota Kaname,Daiko Matsuoka,Yohei Otake, Keisuke Yasuda,Takao Takase, Shuya Takashima,Taro Semba,Kei Muro

crossref（2024）

引用 0|浏览5
暂无评分
摘要

Supplementary Fig S1. Patient dosing and responses over time (A) and anticancer medication received during follow-up (B)

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要